<DOC>
	<DOC>NCT02102971</DOC>
	<brief_summary>The investigators would like to study whether Sirtuin 1 (SIRT1) plays a cytoprotective role in liver ischemia/reperfusion, and ultimately to develop therapeutic strategies to improve hepatic function of patients with liver diseases.</brief_summary>
	<brief_title>Observational Study of Biomarker During Liver Surgery</brief_title>
	<detailed_description>If asked to participate in this research study, it is because a liver resection/liver transplantation surgery has been scheduled. During the procedure a small section will be collected for additional testing of Sirtuin 1. In addition, information concerning the liver disease, laboratory and pathology results after surgery will be collected by the investigators.</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Adenoma</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>liver resection &gt; 2 segments, plate count &gt; 100 x 109/L, and prothrombin activity &gt;60%. liver cirrhosis, portal hypertension, steatohepatitis or severe steatosis, patients receiving additional ablation therapies, laparoscopic resection, and simultaneous extrahepatic procedures such as colorectal resection or pancreatoduodenectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>liver</keyword>
	<keyword>ischemia</keyword>
	<keyword>reperfusion</keyword>
</DOC>